SLC30A8 rs3816873: What Your Genotype Means
The rs3816873 variant is a missense single nucleotide polymorphism in the SLC30A8 gene, encoding the zinc transporter ZnT8. It causes an amino acid substitution (p.Arg325Trp) that has been investigated for its influence on insulin crystallization and glucose regulation. Across genomic studies, alleles at this locus are statistically associated with altered risk profiles and modest protective effects regarding type 2 diabetes mellitus.
What each genotype means
Reduced diabetes risk
Research indicates that this genotype is associated with a reduced risk of developing type 2 diabetes compared to other genotypes. This variant is located in the MTTP gene, which plays a role in lipid metabolism. Please note that genetic associations are statistical in nature and do not determine individual health outcomes.
This genotype is observed in a significant portion of the population, though exact frequencies vary by ancestry.
Typical risk profile
This genotype represents a heterozygous state for the rs3816873 variant. Current scientific literature does not identify a specific, significant clinical impact on diabetes risk for this combination compared to the baseline population. Consult with a healthcare provider if you have concerns about your metabolic health.
This is a common genotype found across diverse global populations.
Typical risk profile
This genotype represents the alternative homozygous state for the rs3816873 variant. There is no established evidence suggesting this specific genotype confers a significant increase or decrease in type 2 diabetes risk. Genetic factors are only one component of metabolic health, and lifestyle factors remain primary considerations.
This genotype is found at varying frequencies globally, consistent with common genetic variation.
Genetic Identity and Biological Mechanism
The single nucleotide polymorphism rs3816873 is located within the SLC30A8 gene on chromosome 8. SLC30A8 provides instructions for producing zinc transporter 8 (ZnT8), a specialized membrane protein heavily expressed in the secretory vesicles of pancreatic beta cells. ZnT8 is responsible for transporting zinc ions from the cytoplasm into insulin storage granules. Zinc is structurally essential for forming stable, insoluble hexamers of insulin before they are secreted into the bloodstream. The missense change alters codon 325 from arginine to tryptophan (p.Arg325Trp), modifying the biochemical properties and activity of the transporter protein. This coding alteration impacts the crystallization dynamics of stored insulin and the subsequent cellular response during metabolic stimulation.
Evidence on Type 2 Diabetes and Metabolic Traits
Early genome-wide association studies identified common variation at the SLC30A8 locus as a key marker for metabolic traits, including fasting plasma glucose and insulin processing. While the p.Arg325Trp site is frequently tagged by companion markers such as rs13266634 in primary literature, direct evaluations of rs3816873 show modest statistical shifts in type 2 diabetes predisposition. Carriers of the protective tryptophan (Trp) allele generally demonstrate improved glucose clearance and altered proinsulin-to-insulin conversion ratios. Although the overarching biological role of SLC30A8 in metabolic health is well supported by broad scientific consensus, direct clinical evidence linking rs3816873 independently to diagnostic outcomes remains limited in scale compared to primary sentinel markers.
Population Distribution and Ancestry Differences
The distribution of alleles at rs3816873 varies considerably across global ancestries. In European populations, the minor allele frequency is estimated at approximately 0.30, meaning that heterozygous carriers and homozygous individuals represent a substantial fraction of the general population. In East Asian populations, the minor allele frequency rises to approximately 0.45, creating a more balanced distribution between the major and minor alleles. These frequency variations highlight the necessity of evaluating metabolic risk in an ancestry-conscious manner. Due to differences in linkage disequilibrium and baseline diabetes prevalence across demographic groups, statistical associations observed in one ancestral background cannot be assumed to carry identical predictive power in another.
Practical Implications and Clinical Perspective
Learning your genotype for rs3816873 provides an educational window into personal biology, but it cannot diagnose or rule out type 2 diabetes. Common variants of this type exert small individual effects on overall metabolic risk. Complex traits like diabetes are governed by hundreds of cumulative genetic factors alongside powerful lifestyle influences, including nutrition, physical activity, sleep, and body composition. Having an allele associated with reduced risk does not confer immunity to metabolic disease, nor does carrying an alternate allele guarantee that a condition will develop. Genetic data should be viewed as one component of broader health literacy and discussed with a qualified medical professional alongside standard clinical screening tests.
How common is this variant?
The minor allele frequency for rs3816873 is roughly 0.30 in European ancestry cohorts and reaches approximately 0.45 in East Asian populations.
Frequently asked questions
What is the function of the SLC30A8 gene?
SLC30A8 encodes zinc transporter 8 (ZnT8), a protein that moves zinc ions into the secretory vesicles of pancreatic beta cells. This zinc is crucial for stabilizing insulin into crystalline structures prior to its release into circulation.
Does having a protective rs3816873 genotype prevent type 2 diabetes?
No, carrying a protective allele only confers a small statistical reduction in relative risk. Lifestyle factors like diet, exercise, and weight, as well as many other genes, play major roles in determining whether someone develops type 2 diabetes.
How does the p.Arg325Trp substitution affect the body?
The p.Arg325Trp substitution alters a single amino acid in the ZnT8 transporter, modifying its structure and activity. This subtle shift affects the storage and maturation of insulin granules, influencing how effectively the pancreas responds to glucose.
Can I use rs3816873 results to change my diabetes medication?
No. Genetic test results from a direct-to-consumer report should never be used to alter medication regimens or doses. Any questions regarding blood sugar management or drug response must be reviewed with your prescribing clinician or a pharmacist.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3816873?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in SLC30A8
This variant in the zinc transporter SLC30A8 is robustly associated with beta-cell function and altered susceptibility to type 2 diabetes.
Well-established missense polymorphism (Arg325Trp) linked to pancreatic zinc transport and altered risk of type 2 diabetes.
Influences zinc-transporter ZnT8 function and modulates fasting glucose and type 2 diabetes risk.
The C allele is associated with altered zinc transport capacity in pancreatic beta-cells and is linked to modulated risk of type 2 diabetes.
This SNP is associated with zinc transporter function and susceptibility to type 2 diabetes.